Investigation of the Effect of Instrument Assisted Soft Tissue Mobilization Technique on Fascia and Fat Tissue Thickness in Healthy Individuals.
1 other identifier
interventional
14
1 country
1
Brief Summary
Instrument-assisted soft tissue mobilization (IASTM) technique can be used for non-pathological conditions as it has been shown in previous literature to affect flexibility and normal range of motion. The use of instrument-assisted soft tissue mobilization technique has been claimed to be an effective treatment in increasing tissue temperature, reducing adhesion to connective tissue and increasing collagen adaptation and increasing flexibility and normal range of motion. The instrument-assisted soft tissue mobilization technique works on the facial connective tissue in the body. This connective tissue contains "sheaths of collagen, which form the cavities and muscle divisions that mainly cover the organs." In some studies, they stated that instrument-assisted soft tissue mobilization increased perfusion, while in some studies they stated that instrument-assisted soft tissue mobilization increased blood circulation. The frequency of ultrasonography (USG) examinations for the musculoskeletal system has increased over time with technological developments and USG has entered daily use in the evaluation of various pathological conditions belonging to this system thanks to its comparable results with MR examinations. The unique advantages of USG such as low cost, easy availability, relatively short examination time, and dynamic real-time comparison with the contralateral side have made it easier to use for musculoskeletal examinations. The aim of this study is to investigate the effect of instrument-assisted soft tissue mobilization technique on strength, flexibility, balance, fascia and adipose tissue thickness in healthy individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2021
CompletedFirst Submitted
Initial submission to the registry
August 13, 2022
CompletedFirst Posted
Study publicly available on registry
August 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedAugust 16, 2022
August 1, 2022
1.4 years
August 13, 2022
August 13, 2022
Conditions
Outcome Measures
Primary Outcomes (12)
Leg Muscle Strength Assessment
The Vertical Jump Test will be used to evaluate the leg muscle strength of individuals.
Pre-treatment assessment.
Leg Muscle Strength Assessment
The Vertical Jump Test will be used to evaluate the leg muscle strength of individuals.
Second assessment immediately after the end of the 10-minute treatment.
Leg Muscle Strength Assessment
The Vertical Jump Test will be used to evaluate the leg muscle strength of individuals.
Control evaluation 1 hour after the end of treatment (third evaluation).
Flexibility Assessment
The sit-and-reach Test will be used to assess the flexibility of individuals.
Pre-treatment assessment.
Flexibility Assessment
The sit-and-reach Test will be used to assess the flexibility of individuals.
Second assessment immediately after the end of the 10-minute treatment.
Flexibility Assessment
The sit-and-reach Test will be used to assess the flexibility of individuals.
Control evaluation 1 hour after the end of treatment (third evaluation).
Balance Assessment
Stork Balance Test will be used to evaluate the balance of individuals.
Pre-treatment assessment.
Balance Assessment
Stork Balance Test will be used to evaluate the balance of individuals.
Second assessment immediately after the end of the 10-minute treatment.
Balance Assessment
Stork Balance Test will be used to evaluate the balance of individuals.
Control evaluation 1 hour after the end of treatment (third evaluation).
Fascia and Adipose Tissue Thickness Assessment
Ultrasound device will be used to measure the thickness of individuals' fascia and adipose tissue.
Pre-treatment assessment.
Fascia and Adipose Tissue Thickness Assessment
Ultrasound device will be used to measure the thickness of individuals' fascia and adipose tissue.
Second assessment immediately after the end of the 10-minute treatment.
Fascia and Adipose Tissue Thickness Assessment
Ultrasound device will be used to measure the thickness of individuals' fascia and adipose tissue.
Control evaluation 1 hour after the end of treatment (third evaluation).
Study Arms (2)
Control Group
OTHERWhich leg of the individuals will be treated will be determined by tossing a coin. After the toss, the right leg will be applied when the tail comes, and the left leg will be applied when it comes to the heads. The leg to be treated, the treatment group of the individuals; the other leg (the untreated leg) will form the control group of the individuals.
IASTM Treatment Group
EXPERIMENTALWhich leg of the individuals will be treated will be determined by tossing a coin. After the toss, the right leg will be applied when the tail comes, and the left leg will be applied when it comes to the heads. The leg to be treated, the treatment group of the individuals; the other leg (the untreated leg) will form the control group of the individuals.
Interventions
Instrument-assisted soft tissue mobilization will be applied to the legs of the individuals to be treated with ultrasound gel for 2 minutes.
Eligibility Criteria
You may qualify if:
- Consists of healthy individuals between the ages of 18-35,
- No history of orthopedic injury (muscle, tendon, joint capsule, ligament damage or peripheral neuropathy) in the lower extremities in the last 1 year,
- Being able to express himself without cognitive, cognitive and mental problems,
- Voluntarily agree to participate in the study.
You may not qualify if:
- Injury to any lower extremity between measurements during the treatment process,
- Having a BMI over 25,
- Surgery or arthritis in the last 1 year,
- Not being able or unwilling to do the tests,
- Not wanting to leave of their own accord.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Inonu Universitylead
Study Sites (1)
Inonu University
Malatya, 44280, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Muhammed Üsame TAŞ, Lecturer
Inonu University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 13, 2022
First Posted
August 16, 2022
Study Start
April 1, 2021
Primary Completion
September 1, 2022
Study Completion
October 1, 2022
Last Updated
August 16, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share